Ethyl 2-chloropyrimidine-4-carboxylate, 95.0%, 10g

2,4-Diethoxybenzoic acid, 97%, 5g

(3aS,7aR)-3,3a,7,7a-Tetrahydroisobenzofuran-1(6H)-one, 250mg

2-METHYL-2-(4-OXETAN-3-YL-PIPERAZIN-1-YL)-PROPIONALDEHYDE, 95.0%, 250mg

Methyl 3-(2-fluorophenyl)-2,2-dimethylpropanoate, 10g

4,4',4'',4'''-([2,2'-Bi(1,3-dithiolylidene)]-4,4',5,5'-tetrayl)tetrabenzoic acid, 97%, 1g

2,2-Di(2-tetrahydrofuryl)propane>96.0%(GC)25mL

4-Fluoro-7-hydroxy-2,3-dihydro-1H-inden-1-one, 95%, 1g

(4-Fluoro-3,5-dimethoxyphenyl)boronic acid, 95.0%, 1g

GC capillary column ROTI®Cap-1, 50 m, 0.32 mm, 3.00 µm, 1 Piece(s)

2-Chloro-6-fluorobenzamide, 95.0%, 100g

3-Chloroacetanilide, 98.0%, 500g

3-(((5-Chloro-3-ethylpyrazolo[1,5-a]pyrimidin-7-yl)amino)methyl)pyridine 1-oxide, 95%, 25mg